Thanks to Pfizer, Drug Pricing Clouds Begin To Clear as Q3 Earnings Roll Out

J&J reports today, just two weeks after Pfizer secured certainty on tariffs and drug pricing. Analysts expect to hear about plans from the rest of the industry during third period earnings calls.

Scroll to Top